MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 10mg tablets (Accord Healthcare Ltd).

Stability Notes

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 10mg tablets (Accord Healthcare Ltd).

Stability Notes

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 10mg tablets (Accord Healthcare Ltd).

Stability Notes

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 25mg tablets (Accord Healthcare Ltd).

Stability Notes

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 25mg tablets (Accord Healthcare Ltd).

Stability Notes

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 25mg tablets (Accord Healthcare Ltd).

Stability Notes

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 25mg tablets (Accord Healthcare Ltd).

Stability Notes

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 25mg tablets (Accord Healthcare Ltd).

Stability Notes

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 25mg tablets (Accord Healthcare Ltd).

Stability Notes

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 25mg tablets (Accord Healthcare Ltd).

Stability Notes

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 25mg tablets (Accord Healthcare Ltd).

Stability Notes

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 25mg tablets (Accord Healthcare Ltd).

Stability Notes

Protect from light and moisture. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Imodium IBS Relief 2mg capsules (McNeil Products Ltd).

Stability Notes

Orodispersible tablet, so unsuitable for inclusion in MCA.

Provenance

This compatibility recommendation is derived from Imodium Instant Melts 2mg orodispersible tablets (McNeil Products Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.